"Ann Intern Med"[journal] 检索结果

161. In symptomatic AF, nurse-led pre-ablation lifestyle treatment reduced repeat ablations or cardioversions at 1 y.

作者: Panteleimon E Papakonstantinou.;Gregory Y H Lip.; .
来源: Ann Intern Med. 2026年179卷1期JC6页

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].

162. Web Exclusive. Annals On Call - Mediterranean Diet in the Management of Irritable Bowel Syndrome.

作者: Robert M Centor.;Imran Aziz.
来源: Ann Intern Med. 2026年179卷1期e2505558OC页

163. Q&A: Commercial cannabis linked to more ED visits.

作者: Gianna Melillo.
来源: Ann Intern Med. 2026年179卷1期IMN5-IMN8页

164. Much ado over acetaminophen.

作者: Stacey Butterfield.
来源: Ann Intern Med. 2026年179卷1期IMN2-IMN5页

165. Introducing I.M. Matters News.

作者: Christine Laine.;Jennifer Kearney-Strouse.
来源: Ann Intern Med. 2026年179卷1期IMN1页

166. In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo.

作者: Andrew Dunn.; .
来源: Ann Intern Med. 2026年179卷1期JC10页

GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

167. Q&A: Past challenges prop up today's politics around gender-affirming care.

作者: Ryan DuBosar.
来源: Ann Intern Med. 2026年179卷2期IMN12-IMN14页

168. In older adults, RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease vs. no vaccine.

作者: Henry S Sacks.; .
来源: Ann Intern Med. 2026年179卷1期JC4页

GIM/FP/GP: [Formula: see text] Geriatrics: [Formula: see text] Infectious Disease: [Formula: see text] Pulmonology: [Formula: see text].

169. In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.

作者: Tess Allan.;L Kristin Newby.; .
来源: Ann Intern Med. 2026年179卷1期JC9页

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].

170. Fight misinformation by acknowledging fears, building trust.

作者: Stacey Butterfield.
来源: Ann Intern Med. 2026年179卷2期IMN14-IMN16页

171. In older adults with impaired physical performance after MI, multidomain rehabilitation reduced CV death or CV hospitalization at 1 y.

作者: Ravishankar Ramaswamy.; .
来源: Ann Intern Med. 2026年179卷1期JC5页

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Geriatrics: [Formula: see text].

172. 2025 brought a bounty of sepsis research.

作者: Stacey Butterfield.
来源: Ann Intern Med. 2026年179卷2期IMN9-IMN11页

173. Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

作者: Vincent Ka Chun Yan.;Joseph Edgar Blais.;John-Michael Gamble.;Esther Wai Yin Chan.;Ian Chi Kei Wong.;Eric Yuk Fai Wan.
来源: Ann Intern Med. 2026年179卷2期157-167页

Whether statins benefit patients with type 2 diabetes mellitus (T2DM) with low predicted 10-year cardiovascular risk is uncertain.

174. 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease.

作者: Amy R Schwartz.;Jonathan Sosnov.;Jonathan Brown.;Cynthia Delgado.;Linda Fried.;Manjula Kurella Tamura.;John W Morrison.;Sankar D Navaneethan.;Paul M Palevsky.;Diane Rybacki.;James Sall.;Sunil Verma.;Maura Watson.;Jesse Wickham.;Mai Nguyen.
来源: Ann Intern Med. 2026年179卷3期411-424页

Management of chronic kidney disease (CKD) has been rapidly evolving, now involving many interventions that can be managed in the primary care setting. In April 2025, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the primary care management of CKD. This synopsis reviews the 2025 recommendations related to diagnosis, assessment, and management of CKD.

175. The Pharmaceutical Industry's Quiet Win in the One Big Beautiful Bill Act.

作者: Shria Bucha.;Matthew J Martin.;William B Feldman.
来源: Ann Intern Med. 2026年179卷3期440-441页

176. Management of Conflicts of Interest in Practice Guidelines: Time to Also Account for Open-Mindedness?

作者: Elie A Akl.;Zachary Munn.;Joanne Khabsa.
来源: Ann Intern Med. 2026年179卷1期132-133页

177. Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.

作者: Amy E Colson.;Gordon E Crofoot.;Peter J Ruane.;Moti N Ramgopal.;Alexandra W Dretler.;Ronald G Nahass.;Gary I Sinclair.;Mezgebe Berhe.;Afsoon Roberts.;Shauna Applin.;Cynthia Brinson.;Dushyantha Jayaweera.;Kimberly A Workowski.;Fadi Shihadeh.;Shan-Yu Liu.;Stephanie Klopfer.;Cyril Llamoso.;Sharline Madera.;Hadas Dvory-Sobol.;Martin S Rhee.;Elizabeth G Rhee.;Jared M Baeten.;Joseph J Eron.
来源: Ann Intern Med. 2026年179卷2期168-176页

Once-weekly oral islatravir plus lenacapavir (ISL+LEN) has the potential to address adherence challenges with daily HIV-1 treatment.

178. The Enemy.

作者: Michael Bretthauer.
来源: Ann Intern Med. 2026年179卷2期296-297页

179. Web Exclusive. Annals Graphic Medicine - "Well, I Did My Own Research…".

作者: Peter Sherman.
来源: Ann Intern Med. 2026年179卷1期e2504697GM页

180. Summary for Patients: Cannabis-Based Products for Chronic Pain.

来源: Ann Intern Med. 2026年179卷2期I22页

结果排序

文献格式

出版时间

出版类型

出版语言